Fehintola A. Ige

Yaba, LA, Nigeria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Journal: Scientific reports

Published: August 20, 2025

SARS-CoV-2 Omicron infection reveals imprinted antibody responses in the absence of vaccination.

SARS-CoV-2 Omicron infection reveals imprinted antibody responses in the absence of vaccination.

Journal: iScience

Published: August 11, 2025

Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults.

Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults.

Journal: Nature communications

Published: July 14, 2025

Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Journal: Scientific reports

Published: December 12, 2024

A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial.

A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial.

Journal: Trials

Published: November 16, 2024

Mpox in endemic regions in Nigeria: awareness, knowledge, and willingness to accept the mpox vaccine.

Mpox in endemic regions in Nigeria: awareness, knowledge, and willingness to accept the mpox vaccine.

Journal: The Pan African medical journal

Published: June 18, 2024

Challenges in conducting population-based seroepidemiology survey of COVID-19 in Lagos State, Nigeria.

Challenges in conducting population-based seroepidemiology survey of COVID-19 in Lagos State, Nigeria.

Journal: BMC public health

Published: June 06, 2023

Seroprevalence of SARS-CoV-2 IgG among healthcare workers in Lagos, Nigeria.

Seroprevalence of SARS-CoV-2 IgG among healthcare workers in Lagos, Nigeria.

Journal: PloS one

Published: January 30, 2023

Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria.

Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria.

Journal: Journal of clinical virology plus

Published: September 05, 2022

SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa.

SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa.

Journal: Nature communications

Published: July 07, 2022

Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey.

Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey.

Journal: PLOS global public health

Published: January 10, 2022

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.

Journal: Microbiology spectrum

Published: October 06, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026